Latest news with #MalathiArshanapalai
Web Release
02-05-2025
- Health
- Web Release
Over 600 medical professionals attended the third edition of Medcare Women and Children Hospital's annual symposium
By Editor_wr Last updated May 1, 2025 The third edition of Medcare Women and Children Hospital's symposium, a specialised annual event dedicated to treating conditions affecting women and children, concluded successfully on Saturday, April 19, 2025, at the Le Meridien Dubai Hotel and Conference Centre. The seven programmes presented highly enriching and engaging discussions on the most significant challenges impacting women and children. The day-long pivotal gathering, themed 'Women's and Children's Health: Advancing Outcomes Through Surgical & Medical Synergy,' focused on the latest healthcare updates, new practices, and most recent developments in the women's and children's medicine landscape. Accredited for Continuing Medical Education (CME) with seven CME points for one-day symposium, the conference drew over 600 healthcare professionals from across the UAE and beyond. The conference featured 27 keynote speakers spanning across trending health topics like obstetrics, gynaecology, neonatology, paediatrics, endocrinology, cardiology, genetics, and emergency medicine. 'The core of maternal and child care must be centred on outcomes,' said Dr. Malathi Arshanapalai, Group Chief Medical and Quality Officer of Aster DM Healthcare. 'This symposium is developed on the foundation of evidence-based medicine, while integrating innovation, collaboration, and clinical excellence. When these elements align, the care we provide to mothers and children becomes the best possible care, ensuring healthier futures for generations to come.' 'This event provides a platform for learning that goes beyond textbooks and traditional training. By listening to experts, observing best practices, and understanding real-world applications, healthcare professionals can refine their approach and improve patient outcomes in tangible ways,' Dr. Malathi added. Dr. Ahmed Abdelhameed, Medical Director of Medcare Women & Children and Medcare Medical Centres, emphasised the holistic approach of the symposium, highlighting the importance of interdisciplinary collaboration in maternal and child health. 'What makes this event truly unique is its ability to bring together not just clinicians, but also allied healthcare providers, including nutritionists, physiotherapists, and mental health specialists, all of whom play a vital role in patient care. By facilitating open discussions and sharing real-world experiences, the symposium ensures that healthcare professionals across specialities can enhance their clinical decision-making, integrate innovative treatments, and collectively work toward achieving optimal health outcomes for both mothers and children.' Highlighting Medcare's leadership in women and children's healthcare in the region, Dr. Abdel Hameed further stated, 'We established this symposium three years ago to elevate the standard of care for women and children across the region. By sharing our expertise in managing complex cases and implementing modern medical advances, we aim to help practitioners refine their capabilities, ultimately improving clinical practice and patient outcomes.' Dr. Azza Gouda, Head of Obstetrics & Gynaecology Department at Medcare Women & Children Hospital stated 'This symposium is not just about theoretical discussions, it is a benchmark event that fosters collaboration and encourages the exchange of best practices among leading experts in the region. Our goal is to make this a recognised annual platform for advancing healthcare excellence in women and child care.' The symposium featured a highly structured agenda, covering foundational and advanced topics that focus women and children's health, some of which included interesting areas like Bowel Endometriosis, Breast Cancer, fertility and PCOS, genetics in new born, placenta previa, recurrent fevers in children, most common paediatric emergencies, and nutritional deficiencies in children. As the Medcare Women & Children Health Symposium continues to evolve, organisers are committed to expanding regional partnerships, integrating global advancements, and shaping the future of woman and child care. 'This symposium is not just about academic knowledge, it's about empowering healthcare professionals to bring world-class standards of care to their communities,' said Dr. Issam Abdelbari Head of Paediatrics Department at Medcare Women & Children Hospital. 'Looking ahead, we aspire to partner with universities for advancing medical student training and elevate this symposium to an international platform, setting new benchmarks for woman and child healthcare across the region.' With groundbreaking discussions, expert-driven case studies, and forward-looking innovations, the third annual MWCH Symposium stands as a beacon for advancing patient care, fostering collaboration, and shaping healthcare excellence for women and children across the region. Comments are closed.
Zawya
01-05-2025
- Health
- Zawya
Over 600 medical professionals attended the third edition of Medcare Women and Children Hospital's annual symposium
Specialists from obstetrics, gynaecology, neonatology, paediatrics, endocrinology, and genetics, gathered at the symposium to discuss cutting-edge advancements in women and child care. Discussions explored topics about the latest and cutting-edge medical treatments and and multidisciplinary strategies for tackling complex health challenges in women and children. Dubai – The third edition of Medcare Women and Children Hospital's symposium, a specialised annual event dedicated to treating conditions affecting women and children, concluded successfully on Saturday, April 19, 2025, at the Le Meridien Dubai Hotel and Conference Centre. The seven programmes presented highly enriching and engaging discussions on the most significant challenges impacting women and children. The day-long pivotal gathering, themed 'Women's and Children's Health: Advancing Outcomes Through Surgical & Medical Synergy,' focused on the latest healthcare updates, new practices, and most recent developments in the women's and children's medicine landscape. Accredited for Continuing Medical Education (CME) with seven CME points for one-day symposium, the conference drew over 600 healthcare professionals from across the UAE and beyond. The conference featured 27 keynote speakers spanning across trending health topics like obstetrics, gynaecology, neonatology, paediatrics, endocrinology, cardiology, genetics, and emergency medicine. 'The core of maternal and child care must be centred on outcomes,' said Dr. Malathi Arshanapalai, Group Chief Medical and Quality Officer of Aster DM Healthcare. 'This symposium is developed on the foundation of evidence-based medicine, while integrating innovation, collaboration, and clinical excellence. When these elements align, the care we provide to mothers and children becomes the best possible care, ensuring healthier futures for generations to come.' 'This event provides a platform for learning that goes beyond textbooks and traditional training. By listening to experts, observing best practices, and understanding real-world applications, healthcare professionals can refine their approach and improve patient outcomes in tangible ways,' Dr. Malathi added. Dr. Ahmed Abdelhameed, Medical Director of Medcare Women & Children and Medcare Medical Centres, emphasised the holistic approach of the symposium, highlighting the importance of interdisciplinary collaboration in maternal and child health. "What makes this event truly unique is its ability to bring together not just clinicians, but also allied healthcare providers, including nutritionists, physiotherapists, and mental health specialists, all of whom play a vital role in patient care. By facilitating open discussions and sharing real-world experiences, the symposium ensures that healthcare professionals across specialities can enhance their clinical decision-making, integrate innovative treatments, and collectively work toward achieving optimal health outcomes for both mothers and children." Highlighting Medcare's leadership in women and children's healthcare in the region, Dr. Abdel Hameed further stated, 'We established this symposium three years ago to elevate the standard of care for women and children across the region. By sharing our expertise in managing complex cases and implementing modern medical advances, we aim to help practitioners refine their capabilities, ultimately improving clinical practice and patient outcomes.' Dr. Azza Gouda, Head of Obstetrics & Gynaecology Department at Medcare Women & Children Hospital stated 'This symposium is not just about theoretical discussions, it is a benchmark event that fosters collaboration and encourages the exchange of best practices among leading experts in the region. Our goal is to make this a recognised annual platform for advancing healthcare excellence in women and child care.' The symposium featured a highly structured agenda, covering foundational and advanced topics that focus women and children's health, some of which included interesting areas like Bowel Endometriosis, Breast Cancer, fertility and PCOS, genetics in new born, placenta previa, recurrent fevers in children, most common paediatric emergencies, and nutritional deficiencies in children. As the Medcare Women & Children Health Symposium continues to evolve, organisers are committed to expanding regional partnerships, integrating global advancements, and shaping the future of woman and child care. 'This symposium is not just about academic knowledge, it's about empowering healthcare professionals to bring world-class standards of care to their communities,' said Dr. Issam Abdelbari Head of Paediatrics Department at Medcare Women & Children Hospital. 'Looking ahead, we aspire to partner with universities for advancing medical student training and elevate this symposium to an international platform, setting new benchmarks for woman and child healthcare across the region.' With groundbreaking discussions, expert-driven case studies, and forward-looking innovations, the third annual MWCH Symposium stands as a beacon for advancing patient care, fostering collaboration, and shaping healthcare excellence for women and children across the region. About Medcare Women & Children Hospital Medcare Women & Children Hospital is a flagship facility under the Medcare network, dedicated to offering world-class medical care for women and children. Specialties include obstetrics, gynaecology, fertility, paediatrics, neonatology, and adolescent medicine. MWCH is part of the Aster DM Healthcare group, one of the largest integrated healthcare providers in the region. For media queries, please contact: Akshara Suresh Watermelon Communications Dubai, UAE akshara@
Web Release
15-04-2025
- Health
- Web Release
Aster Hospital Mankhool Introduces Cutting-Edge Robotic Orthopedic Centre
By Editor_wr On Apr 15, 2025 Aster Hospital Mankhool, ranked No. 4 on Newsweek's World's Best Hospitals in the UAE list for 2025, has launched its state-of-the-art Robotic Surgery Centre, marking a significant advancement in orthopedic care with the introduction of the ROSA® Robotic Knee Joint Replacement System. This cutting-edge robotic surgical assistant works alongside surgeons from pre-surgery planning through to the procedure itself, enhancing accuracy and reducing the risk of surgical errors in bone preparation and implant placement. As the first robotic surgery facility within Aster Hospitals in the UAE, this milestone underscores the hospital's commitment to providing world-class, technology-driven healthcare solutions. The Robotic Surgery Centre was officially inaugurated by Olympic boxing legend and former Rajya Sabha Member, Mary Kom, who lauded the hospital's commitment to innovation and patient-centric advancements in healthcare. Studies indicate that the global knee replacement market is projected to reach USD 17.35 billion by 20341, driven by an increasing aging population, osteoarthritis and rising patient demand for effective, long-lasting treatments. Robotic-assisted knee replacement surgery addresses the challenges of traditional procedures by offering greater precision, reducing recovery time, and improving implant longevity. ROSA® assists surgeons by generating a 3D model of the patient's knee using preoperative CT scans (rather than X-rays), enabling a highly personalized and accurate surgical approach. By providing real-time data and intraoperative feedback, the system ensures optimal implant positioning, reduces surgical errors, and enhances joint function. The robotic assistance allows for customized treatment plans tailored to each patient's unique anatomy, significantly improving overall results. Commenting on the launch, Dr. Malathi Arshanapalai, Group Chief Medical Officer and Group Chief Quality Officer, Aster DM Healthcare, said 'At Aster, we are committed to continuously innovating and adopting advanced technologies that improve patient outcomes. The introduction of the robotic knee joint replacement system at Aster Hospital Mankhool is a testament to our vision of making high-quality, technology-driven healthcare accessible to our patients. With robotic-assisted surgery, we are bringing the future of orthopedic care to the region, ensuring more precision, faster recovery, and better overall experiences for patients undergoing knee replacement procedures.' The adoption of robotic-assisted knee replacement surgery at Aster Hospital Mankhool includes both knee and hip replacement surgeries, bringing multiple advantages over traditional procedures. Patients benefit from smaller incisions, minimal tissue disruption, and a reduced risk of complications, such as infections and nerve damage. The advanced technology enhances joint stability, ensuring proper alignment and lowering the risk of misalignment-related issues. Moreover, the precision of robotic assistance leads to improved implant longevity, potentially extending the lifespan of the prosthetic knee. Dr. Ranjith Narayan, Specialist Orthopaedics, Aster Hospital Mankhool, added, 'The introduction of the ROSA® Robotic Knee Joint Replacement System at Aster Hospital Mankhool is a game-changer in orthopedic care. This advanced robotic system enhances surgical precision by utilizing real-time data and 3D modeling, allowing for a highly personalized approach tailored to each patient's unique anatomy. By ensuring optimal implant positioning and minimizing surgical errors, the technology significantly improves joint function, reduces recovery time, and enhances overall patient outcomes. With robotic-assisted surgery, we are not only elevating the standard of knee replacement procedures but also providing our patients with a safer, more effective, and long-lasting treatment solution.' With reduced postoperative pain and a faster rehabilitation process, patients can expect shorter hospital stays and quicker recovery times. The minimally invasive nature of robotic-assisted surgery also reduces blood loss and promotes faster healing, contributing to an improved quality of life for individuals undergoing both knee and hip replacement surgeries. This technology is particularly beneficial for patients with severe arthritis or complex anatomical structures, offering them an advanced surgical solution for enhanced mobility and long-term joint health. With this introduction, Aster Hospital Mankhool reaffirms its commitment to integrating innovation and excellence into patient care. This launch represents a transformative step forward in orthopedic treatment, ensuring that patients receive the most precise, effective, and minimally invasive surgical interventions available. Aster Hospital Mankhool Introduces Cutting-Edge Robotic Orthopedic Centre Comments are closed.
Mid East Info
15-04-2025
- Health
- Mid East Info
Aster Hospital Mankhool Introduces Cutting-Edge Robotic Orthopedic Centre - Middle East Business News and Information
Aster Hospital Mankhool, ranked No. 4 on Newsweek's World's Best Hospitals in the UAE list for 2025, has launched its state-of-the-art Robotic Surgery Centre, marking a significant advancement in orthopedic care with the introduction of the ROSA® Robotic Knee Joint Replacement System. This cutting-edge robotic surgical assistant works alongside surgeons from pre-surgery planning through to the procedure itself, enhancing accuracy and reducing the risk of surgical errors in bone preparation and implant placement. As the first robotic surgery facility within Aster Hospitals in the UAE, this milestone underscores the hospital's commitment to providing world-class, technology-driven healthcare solutions. The Robotic Surgery Centre was officially inaugurated by Olympic boxing legend and former Rajya Sabha Member, Mary Kom, who lauded the hospital's commitment to innovation and patient-centric advancements in healthcare. Studies indicate that the global knee replacement market is projected to reach USD 17.35 billion by 20341, driven by an increasing aging population, osteoarthritis and rising patient demand for effective, long-lasting treatments. Robotic-assisted knee replacement surgery addresses the challenges of traditional procedures by offering greater precision, reducing recovery time, and improving implant longevity. ROSA® assists surgeons by generating a 3D model of the patient's knee using preoperative CT scans (rather than X-rays), enabling a highly personalized and accurate surgical approach. By providing real-time data and intraoperative feedback, the system ensures optimal implant positioning, reduces surgical errors, and enhances joint function. The robotic assistance allows for customized treatment plans tailored to each patient's unique anatomy, significantly improving overall results. Commenting on the launch, Dr. Malathi Arshanapalai, Group Chief Medical Officer and Group Chief Quality Officer, Aster DM Healthcare, said 'At Aster, we are committed to continuously innovating and adopting advanced technologies that improve patient outcomes. The introduction of the robotic knee joint replacement system at Aster Hospital Mankhool is a testament to our vision of making high-quality, technology-driven healthcare accessible to our patients. With robotic-assisted surgery, we are bringing the future of orthopedic care to the region, ensuring more precision, faster recovery, and better overall experiences for patients undergoing knee replacement procedures.' The adoption of robotic-assisted knee replacement surgery at Aster Hospital Mankhool includes both knee and hip replacement surgeries, bringing multiple advantages over traditional procedures. Patients benefit from smaller incisions, minimal tissue disruption, and a reduced risk of complications, such as infections and nerve damage. The advanced technology enhances joint stability, ensuring proper alignment and lowering the risk of misalignment-related issues. Moreover, the precision of robotic assistance leads to improved implant longevity, potentially extending the lifespan of the prosthetic knee. Dr. Ranjith Narayan, Specialist Orthopaedics, Aster Hospital Mankhool, added, 'The introduction of the ROSA® Robotic Knee Joint Replacement System at Aster Hospital Mankhool is a game-changer in orthopedic care. This advanced robotic system enhances surgical precision by utilizing real-time data and 3D modeling, allowing for a highly personalized approach tailored to each patient's unique anatomy. By ensuring optimal implant positioning and minimizing surgical errors, the technology significantly improves joint function, reduces recovery time, and enhances overall patient outcomes. With robotic-assisted surgery, we are not only elevating the standard of knee replacement procedures but also providing our patients with a safer, more effective, and long-lasting treatment solution.' With reduced postoperative pain and a faster rehabilitation process, patients can expect shorter hospital stays and quicker recovery times. The minimally invasive nature of robotic-assisted surgery also reduces blood loss and promotes faster healing, contributing to an improved quality of life for individuals undergoing both knee and hip replacement surgeries. This technology is particularly beneficial for patients with severe arthritis or complex anatomical structures, offering them an advanced surgical solution for enhanced mobility and long-term joint health. With this introduction, Aster Hospital Mankhool reaffirms its commitment to integrating innovation and excellence into patient care. This launch represents a transformative step forward in orthopedic treatment, ensuring that patients receive the most precise, effective, and minimally invasive surgical interventions available.
Zawya
15-04-2025
- Business
- Zawya
Aster Hospital Mankhool introduces cutting-edge robotic orthopedic centre
Launches state-of-the-art Robotic Surgery Centre with introduction of ROSA® Robotic Knee Joint Replacement System featuring real-time data, 3D modeling, and a personalized surgical approach for enhanced accuracy. Studies indicate that the global knee replacement market is projected to reach USD 17.35 billion by 20341, driven by an increasing aging population, osteoarthritis and rising patient demand for effective, long-lasting treatments. Reinforces its commitment to innovation and advancing Orthopedic care in the region – ensuring precision, faster recovery, and improved patient experiences. Dubai, UAE: Aster Hospital Mankhool, ranked No. 4 on Newsweek's World's Best Hospitals in the UAE list for 2025, has launched its state-of-the-art Robotic Surgery Centre, marking a significant advancement in orthopedic care with the introduction of the ROSA® Robotic Knee Joint Replacement System. This cutting-edge robotic surgical assistant works alongside surgeons from pre-surgery planning through to the procedure itself, enhancing accuracy and reducing the risk of surgical errors in bone preparation and implant placement. As the first robotic surgery facility within Aster Hospitals in the UAE, this milestone underscores the hospital's commitment to providing world-class, technology-driven healthcare solutions. The Robotic Surgery Centre was officially inaugurated by Olympic boxing legend and former Rajya Sabha Member, Mary Kom, who lauded the hospital's commitment to innovation and patient-centric advancements in healthcare. Studies indicate that the global knee replacement market is projected to reach USD 17.35 billion by 20341, driven by an increasing aging population, osteoarthritis and rising patient demand for effective, long-lasting treatments. Robotic-assisted knee replacement surgery addresses the challenges of traditional procedures by offering greater precision, reducing recovery time, and improving implant longevity. ROSA® assists surgeons by generating a 3D model of the patient's knee using preoperative CT scans (rather than X-rays), enabling a highly personalized and accurate surgical approach. By providing real-time data and intraoperative feedback, the system ensures optimal implant positioning, reduces surgical errors, and enhances joint function. The robotic assistance allows for customized treatment plans tailored to each patient's unique anatomy, significantly improving overall results. Commenting on the launch, Dr. Malathi Arshanapalai, Group Chief Medical Officer and Group Chief Quality Officer, Aster DM Healthcare, said "At Aster, we are committed to continuously innovating and adopting advanced technologies that improve patient outcomes. The introduction of the robotic knee joint replacement system at Aster Hospital Mankhool is a testament to our vision of making high-quality, technology-driven healthcare accessible to our patients. With robotic-assisted surgery, we are bringing the future of orthopedic care to the region, ensuring more precision, faster recovery, and better overall experiences for patients undergoing knee replacement procedures." The adoption of robotic-assisted knee replacement surgery at Aster Hospital Mankhool includes both knee and hip replacement surgeries, bringing multiple advantages over traditional procedures. Patients benefit from smaller incisions, minimal tissue disruption, and a reduced risk of complications, such as infections and nerve damage. The advanced technology enhances joint stability, ensuring proper alignment and lowering the risk of misalignment-related issues. Moreover, the precision of robotic assistance leads to improved implant longevity, potentially extending the lifespan of the prosthetic knee. Dr. Ranjith Narayan, Specialist Orthopaedics, Aster Hospital Mankhool, added, "The introduction of the ROSA® Robotic Knee Joint Replacement System at Aster Hospital Mankhool is a game-changer in orthopedic care. This advanced robotic system enhances surgical precision by utilizing real-time data and 3D modeling, allowing for a highly personalized approach tailored to each patient's unique anatomy. By ensuring optimal implant positioning and minimizing surgical errors, the technology significantly improves joint function, reduces recovery time, and enhances overall patient outcomes. With robotic-assisted surgery, we are not only elevating the standard of knee replacement procedures but also providing our patients with a safer, more effective, and long-lasting treatment solution.' With reduced postoperative pain and a faster rehabilitation process, patients can expect shorter hospital stays and quicker recovery times. The minimally invasive nature of robotic-assisted surgery also reduces blood loss and promotes faster healing, contributing to an improved quality of life for individuals undergoing both knee and hip replacement surgeries. This technology is particularly beneficial for patients with severe arthritis or complex anatomical structures, offering them an advanced surgical solution for enhanced mobility and long-term joint health. With this introduction, Aster Hospital Mankhool reaffirms its commitment to integrating innovation and excellence into patient care. This launch represents a transformative step forward in orthopedic treatment, ensuring that patients receive the most precise, effective, and minimally invasive surgical interventions available. About Aster DM Healthcare Founded in 1987 by Dr. Azad Moopen, Aster DM Healthcare is a leading integrated healthcare provider, with a strong presence across all six countries in the GCC and Jordan. Aster is committed to the vision of providing accessible and high-quality healthcare, from primary to quaternary services, with its promise of 'We will treat you well'. The organisation's robust integrated healthcare model includes 15 hospitals, 122 clinics, and 313 pharmacies in GCC serving all segments of the society through three differentiated brands: Aster, Medcare and Access. Aster consistently adapts to meet the evolving needs of patients, ensuring access to quality healthcare through both physical and digital channels which is exemplified with the launch of the region's first healthcare super app, myAster. With a steadfast focus on innovation and patient-centric approach, the organisation's dedicated team of 1859 doctors and 3867 nurses are committed to delivering world-class healthcare services across a diverse spectrum of medical and surgical specialties. For more information about us, please contact:
